ES8601692A1 - Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo - Google Patents

Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Info

Publication number
ES8601692A1
ES8601692A1 ES539289A ES539289A ES8601692A1 ES 8601692 A1 ES8601692 A1 ES 8601692A1 ES 539289 A ES539289 A ES 539289A ES 539289 A ES539289 A ES 539289A ES 8601692 A1 ES8601692 A1 ES 8601692A1
Authority
ES
Spain
Prior art keywords
cream
active compounds
high release
antimycotic agent
antimycotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539289A
Other languages
English (en)
Other versions
ES539289A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES539289A0 publication Critical patent/ES539289A0/es
Publication of ES8601692A1 publication Critical patent/ES8601692A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

METODO DE PREPARACION PARA EL BIFONAZOL DE FORMULA (I). SE HACE REACCIONAR EL HALOGENO METANO DE FORMULA (II) CON IMIDAZOL EN PRESENCIA DE UN AGENTE ACEPTOR DE ACIDO Y DE UN DILUYENTE O CON LAS SALES DE PLATA O ALCALINAS DEL IMIDAZOL EN PRESENCIA DE UN DILUYENTE. EL AZOLIL-(1)-METANO OBTENIDO SE HACE REACCIONAR CON ACIDOS FISIOLOGICAMENTE TOLERABLES. SE MEZCLA CON 10 A 60 UNIDADES DE AGENTE EXTENDEDOR Y DE 20 A 80 UNIDADES EN PESO DE DISOLVENTE. SE PUEDE ADICIONAR UN PROPULSOR PARA UTILIZARLO COMO SPRAY. APLICABLE COMO ANTIMICOTICO.
ES539289A 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo Expired ES8601692A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
ES539289A0 ES539289A0 (es) 1985-11-16
ES8601692A1 true ES8601692A1 (es) 1985-11-16

Family

ID=6195162

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530846A Granted ES530846A0 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539289A Expired ES8601692A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Expired ES8601693A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES530846A Granted ES530846A0 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES539290A Expired ES8601693A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Country Status (19)

Country Link
JP (1) JPS59184106A (es)
KR (1) KR840008284A (es)
AU (1) AU564956B2 (es)
BE (1) BE899278A (es)
CA (1) CA1212327A (es)
CH (1) CH660126A5 (es)
CY (1) CY1358A (es)
DE (1) DE3311701A1 (es)
ES (3) ES530846A0 (es)
FR (1) FR2543435B1 (es)
GB (1) GB2137091B (es)
GR (1) GR81485B (es)
IT (1) IT1173761B (es)
KE (1) KE3704A (es)
LU (1) LU85271A1 (es)
PH (1) PH20420A (es)
PT (1) PT78313B (es)
SE (1) SE8401748L (es)
ZA (1) ZA842337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
AU4399793A (en) * 1992-06-08 1994-01-04 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CY1358A (en) 1987-08-07
ES539290A0 (es) 1985-11-16
GB2137091A (en) 1984-10-03
ES539289A0 (es) 1985-11-16
SE8401748L (sv) 1984-10-01
ES8601693A1 (es) 1985-11-16
AU564956B2 (en) 1987-09-03
SE8401748D0 (sv) 1984-03-29
LU85271A1 (de) 1984-11-14
ES8503947A1 (es) 1985-04-16
JPS59184106A (ja) 1984-10-19
CH660126A5 (de) 1987-03-31
GB2137091B (en) 1986-10-01
IT8420303A0 (it) 1984-03-29
PH20420A (en) 1987-01-05
CA1212327A (en) 1986-10-07
PT78313B (en) 1986-06-02
KR840008284A (ko) 1984-12-14
GB8408067D0 (en) 1984-05-10
IT1173761B (it) 1987-06-24
FR2543435A1 (fr) 1984-10-05
KE3704A (en) 1987-03-27
BE899278A (fr) 1984-10-01
ZA842337B (en) 1984-11-28
DE3311701A1 (de) 1984-10-04
PT78313A (en) 1984-04-01
ES530846A0 (es) 1985-04-16
GR81485B (es) 1984-12-11
AU2623684A (en) 1984-10-04
FR2543435B1 (fr) 1988-06-17

Similar Documents

Publication Publication Date Title
HUT57541A (en) Fungicidal compositions comprising substituted acrylic acid esters as active ingredient and process for producing the active ingredients
ATE11219T1 (de) Antimykotische mittel in emulsionsform mit hoher wirkstoff-freisetzung.
ES8200123A1 (es) Un procedimiento para la produccion de un ester de coleste- rol
GB8528201D0 (en) Margarine &c fat compositions
ES2051827T3 (es) Una composicion farmaceutica que contiene aceite de ricino polietoxilado.
EP0133030A3 (en) Water-soluble coolant for formation of drawn and ironed cans
MY100070A (en) Hair rinse composition
JPS5640605A (en) Cosmetic
NZ197293A (en) Pour-on anthelmintic compositions containing tetramisole and/or levamisole
ES8601693A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
JPS52806A (en) Preparation of ester
JPS5549313A (en) Vitamin pharmaceutical and its preparation
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
SE8301565D0 (sv) Oljeloslig komposition innehallande fettloslig vitamin
JPS5421979A (en) Composition for emulsifying agnet or sulubilizing agnet
KR840007522A (ko) 지방산 함유 양모제 조성물
JPS55133306A (en) Perfume controller
JPS56131344A (en) Preparation of foaming fat or oil for cake
JPS5672651A (en) Fats and oils for spray
JPS565436A (en) Preparation of carboxylic acid ester
JPS5751746A (en) Thermoplastic resin composition
JPS545948A (en) Cyclopropanecarboxylic acid esters, process for their prparation, and isecticide having low toxicity to fishees, containing the same as active constituents
MY110558A (en) Patty acid salts and esters derived from palm oil, and soap compositions containing same.
JPS537627A (en) Optically active unsaturated esters and their preparation
JPS6411187A (en) Antioxidant

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050723